| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LUMOS PHARMA, INC. | Chief Business Officer | Common Stock | 0 | $0 | $1.89 | 12 Dec 2024 | Direct |
| LUMOS PHARMA, INC. | Chief Business Officer | Stock Option (Right to Buy) | 0 | 12 Dec 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| (LUMO) | LUMOS PHARMA, INC. | 12 Dec 2024 | 7 | $0 | 4 | Chief Business Officer | 13 Dec 2024, 21:31 |
| (LUMO) | LUMOS PHARMA, INC. | 01 Apr 2024 | 2 | +$2,840 | 4 | Chief Business Officer | 03 Apr 2024, 17:09 |
| (LUMO) | LUMOS PHARMA, INC. | 01 Feb 2024 | 1 | -$608 | 4 | Chief Business Officer | 05 Feb 2024, 17:52 |
| LUMO | LUMOS PHARMA, INC. | 01 Feb 2023 | 3 | +$3,154 | 4 | Chief Business Officer | 03 Feb 2023, 16:04 |
| LUMO | LUMOS PHARMA, INC. | 01 Feb 2022 | 3 | +$9,499 | 4 | Chief Business Officer | 03 Feb 2022, 15:37 |
| LUMO | LUMOS PHARMA, INC. | 11 Aug 2021 | 2 | +$14,819 | 4 | Chief Business Officer | 13 Aug 2021, 16:32 |
| LUMO | LUMOS PHARMA, INC. | 01 Jun 2021 | 1 | $0 | 4 | Chief Business Officer | 03 Jun 2021, 16:52 |
| LUMO | LUMOS PHARMA, INC. | 19 May 2021 | 0 | $0 | 3 | Chief Business Officer | 28 May 2021, 19:03 |